Reductions in Raldh2 expression and RA signaling have been found in postmortem samples of patients with human amyotrophic lateral sclerosis (ALS) and Alzheimer's disease [100], [101], both exhibiting neurodegenerative phenotypes. The gene discussed is ALDH1A2; the disease is Alzheimer disease.